NYRADA INC. - Announcements

1.72%

28.5¢

Market Cap $68.05M

Healthcare Biotechnology

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Recce Pharmaceuticals (ASX:RCE) eyes US Defence grants with early data for R327 on burn wounds

Announcements

Filter Results

All Price Sensitive Only

NYR	Change of Director's Interest Notice - ID		18/01/21	454.4KB	Share
NYR	Appendix 3G		18/01/21	274.57KB	Share
NYR	Appendix 3G		18/01/21	277.62KB	Share
NYR	Appendix 3G		18/01/21	263.69KB	Share
NYR	Release of Securities from Escrow		07/01/21	190KB	Share
NYR	Change in substantial holding		06/01/21	198.73KB	Share
NYR	57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study	PRICE SENSITIVE	21/12/20	307.97KB	Share
NYR	Appointment of New Auditor		14/12/20	177.42KB	Share
NYR	Change in substantial holding		08/12/20	183.76KB	Share
NYR	Cleansing Statement		02/12/20	207.09KB	Share
NYR	Appendix 2A		02/12/20	279.88KB	Share
NYR	Change of Director's Interest Notice - JM		26/11/20	173.53KB	Share
NYR	Change of Director's Interest Notice - MF		25/11/20	180.26KB	Share
NYR	Appendix 2A		25/11/20	278.54KB	Share
NYR	Nyrada Annual General Meeting Results		19/11/20	237.87KB	Share
NYR	Presentation to 2020 Annual General Meeting of Shareholders		19/11/20	1.25MB	Share
NYR	Nyrada AGM 2020 Chairmans Address		19/11/20	203.44KB	Share
NYR	Release of Securities from Escrow		16/11/20	160.02KB	Share
NYR	Unlisted Convertible Note Options Expiring 30 November 2020		09/11/20	183.78KB	Share
NYR	2020 Annual General Meeting Reminder		03/11/20	192.15KB	Share
NYR	Letter to Shareholders and Proxy Form in relation to AGM		19/10/20	769.02KB	Share
NYR	Notice of Annual General Meeting and Proxy Form		19/10/20	2.91MB	Share
NYR	Nyrada Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	13/10/20	460.69KB	Share
NYR	Nyrada Newsletter September 2020		24/09/20	619.58KB	Share
NYR	Notification of Date of 2020 Annual General Meeting		17/09/20	192.13KB	Share
NYR	Change of Director's Interest Notice - JM		11/09/20	173.39KB	Share
NYR	Nyrada Investor Webinar		09/09/20	179.62KB	Share
NYR	Initial Director's Interest Notice - ID		08/09/20	183.5KB	Share
NYR	Final Director's Interest Notice - GK		08/09/20	233.77KB	Share
NYR	Annual Report to 30 June 2020		08/09/20	3.34MB	Share
NYR	Appendix 4G and Corporate Governance Statement		08/09/20	681.02KB	Share
NYR	Preliminary Final Report	PRICE SENSITIVE	31/08/20	388.18KB	Share
NYR	Nyrada Board Changes		31/08/20	199.5KB	Share
NYR	Nyrada Global Webcast Invitation		30/07/20	183.67KB	Share
NYR	Nyrada A$1.0M R&D Tax Rebate & Use of Funds Annexure	PRICE SENSITIVE	29/07/20	206KB	Share
NYR	Nyrada Roadshow Corporate Presentation		23/07/20	1.52MB	Share
NYR	Nyrada Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	22/07/20	331.58KB	Share
NYR	Nyrada Brain Injury Drug Pharmacokinetic Study Results	PRICE SENSITIVE	15/07/20	259.66KB	Share
NYR	Nyrada Brain Injury Data Published by US Health Conference		09/07/20	224.45KB	Share
NYR	Change in substantial holding		08/07/20	150.46KB	Share
NYR	Nyrada Cholesterol-Lowering Drug Study Results	PRICE SENSITIVE	06/07/20	230.95KB	Share
NYR	Nyrada Newsletter June 2020		25/06/20	317.56KB	Share
NYR	Corporate Presentation for the Reach Markets Virtual Event		24/06/20	1.48MB	Share
NYR	Milestone Achieved in the Nyrada Brain Injury Program	PRICE SENSITIVE	25/05/20	227.68KB	Share
NYR	Nyrada Preclinical Program & Corporate Update Presentation		30/04/20	1.57MB	Share
NYR	Change of Director's Interest Notice - JM		27/04/20	208.98KB	Share
NYR	Appointment of New Chief Financial Officer		22/04/20	183.27KB	Share
NYR	Preclinical Program & Corporate Update Global Webinar		20/04/20	184.56KB	Share
NYR	Appendix 4C - March 2020 quarterly	PRICE SENSITIVE	14/04/20	1.17MB	Share
NYR	Nyrada Newsletter Released		06/04/20	573.4KB	Share
NYR	Update on Progress in Nyrada Programs		16/03/20	207.21KB	Share
NYR	Nyrada Inc. Corporate Presentation February 2020		27/02/20	1.07MB	Share
NYR	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	25/02/20	943.38KB	Share
NYR	Significant advance in Nyrada PCSK9i program published		11/02/20	6.22MB	Share
NYR	Nyrada Inc - Chairman's letter to shareholders		20/01/20	241.39KB	Share
NYR	Becoming a substantial holder		20/01/20	147.96KB	Share
NYR	Nyrada Inc - Corporate Presentation		17/01/20	573.41KB	Share
NYR	NOX: Listing of Nyrada Inc. spin-off on ASX		16/01/20	200.37KB	Share
NYR	NYR Commences Trading on the ASX		16/01/20	345.32KB	Share
NYR	Becoming a substantial holder		16/01/20	89.96KB	Share
NYR	Becoming a substantial holder		16/01/20	82.94KB	Share
NYR	Initial Director's Interest Notice		16/01/20	162.13KB	Share
NYR	Initial Director's Interest Notice		16/01/20	165.68KB	Share
NYR	Initial Director's Interest Notice		16/01/20	163.94KB	Share
NYR	Initial Director's Interest Notice		16/01/20	162.98KB	Share
NYR	Initial Director's Interest Notice		16/01/20	171.7KB	Share
NYR	Initial Director's Interest Notice		16/01/20	165.45KB	Share
NYR	Regulation S-Foreign Ownership Restrictions		15/01/20	767.37KB	Share
NYR	Confirmation and Waiver under ASX Listing Rules		14/01/20	119.22KB	Share
NYR	Pre-Quotation Disclosure		14/01/20	379.96KB	Share
NYR	Updated Pro-forma - Financial Position and Commitments		14/01/20	128.46KB	Share
NYR	Securities Trading Policy		14/01/20	153.48KB	Share
NYR	Capital Structure and Restricted Securities		14/01/20	85.05KB	Share
NYR	Financial Statements Year End 30 June 2019		14/01/20	937.93KB	Share
NYR	Financial Statements Year End 30 June 2018		14/01/20	1.26MB	Share
NYR	Corporate Governance Statement		14/01/20	331.77KB	Share
NYR	Equity Incentive Plan		14/01/20	219.27KB	Share
NYR	Amended and Restated Certificate of Incorporation and Bylaws		14/01/20	1.49MB	Share
NYR	Supplementary Prospectus		14/01/20	92.64KB	Share
NYR	Prospectus		14/01/20	4.48MB	Share
NYR	Appendix 1A, Information Form and Checklist, Annexure 3		14/01/20	272.28KB	Share
NYR	Distribution Schedule		14/01/20	63.39KB	Share
NYR	Top 20 Securityholders		14/01/20	85.07KB	Share
NYR	ASX Market Release - Admission and Quotation		14/01/20	252.98KB	Share

NYR Change of Director's Interest Notice - ID
18/01/21		454.4KB	Share
NYR Appendix 3G
18/01/21		274.57KB	Share
NYR Appendix 3G
18/01/21		277.62KB	Share
NYR Appendix 3G
18/01/21		263.69KB	Share
NYR Release of Securities from Escrow
07/01/21		190KB	Share
NYR Change in substantial holding
06/01/21		198.73KB	Share
NYR 57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
21/12/20	PRICE SENSITIVE	307.97KB	Share
NYR Appointment of New Auditor
14/12/20		177.42KB	Share
NYR Change in substantial holding
08/12/20		183.76KB	Share
NYR Cleansing Statement
02/12/20		207.09KB	Share
NYR Appendix 2A
02/12/20		279.88KB	Share
NYR Change of Director's Interest Notice - JM
26/11/20		173.53KB	Share
NYR Change of Director's Interest Notice - MF
25/11/20		180.26KB	Share
NYR Appendix 2A
25/11/20		278.54KB	Share
NYR Nyrada Annual General Meeting Results
19/11/20		237.87KB	Share
NYR Presentation to 2020 Annual General Meeting of Shareholders
19/11/20		1.25MB	Share
NYR Nyrada AGM 2020 Chairmans Address
19/11/20		203.44KB	Share
NYR Release of Securities from Escrow
16/11/20		160.02KB	Share
NYR Unlisted Convertible Note Options Expiring 30 November 2020
09/11/20		183.78KB	Share
NYR 2020 Annual General Meeting Reminder
03/11/20		192.15KB	Share
NYR Letter to Shareholders and Proxy Form in relation to AGM
19/10/20		769.02KB	Share
NYR Notice of Annual General Meeting and Proxy Form
19/10/20		2.91MB	Share
NYR Nyrada Quarterly Activities Report & Appendix 4C
13/10/20	PRICE SENSITIVE	460.69KB	Share
NYR Nyrada Newsletter September 2020
24/09/20		619.58KB	Share
NYR Notification of Date of 2020 Annual General Meeting
17/09/20		192.13KB	Share
NYR Change of Director's Interest Notice - JM
11/09/20		173.39KB	Share
NYR Nyrada Investor Webinar
09/09/20		179.62KB	Share
NYR Initial Director's Interest Notice - ID
08/09/20		183.5KB	Share
NYR Final Director's Interest Notice - GK
08/09/20		233.77KB	Share
NYR Annual Report to 30 June 2020
08/09/20		3.34MB	Share
NYR Appendix 4G and Corporate Governance Statement
08/09/20		681.02KB	Share
NYR Preliminary Final Report
31/08/20	PRICE SENSITIVE	388.18KB	Share
NYR Nyrada Board Changes
31/08/20		199.5KB	Share
NYR Nyrada Global Webcast Invitation
30/07/20		183.67KB	Share
NYR Nyrada A$1.0M R&D Tax Rebate & Use of Funds Annexure
29/07/20	PRICE SENSITIVE	206KB	Share
NYR Nyrada Roadshow Corporate Presentation
23/07/20		1.52MB	Share
NYR Nyrada Quarterly Activities Report & Appendix 4C
22/07/20	PRICE SENSITIVE	331.58KB	Share
NYR Nyrada Brain Injury Drug Pharmacokinetic Study Results
15/07/20	PRICE SENSITIVE	259.66KB	Share
NYR Nyrada Brain Injury Data Published by US Health Conference
09/07/20		224.45KB	Share
NYR Change in substantial holding
08/07/20		150.46KB	Share
NYR Nyrada Cholesterol-Lowering Drug Study Results
06/07/20	PRICE SENSITIVE	230.95KB	Share
NYR Nyrada Newsletter June 2020
25/06/20		317.56KB	Share
NYR Corporate Presentation for the Reach Markets Virtual Event
24/06/20		1.48MB	Share
NYR Milestone Achieved in the Nyrada Brain Injury Program
25/05/20	PRICE SENSITIVE	227.68KB	Share
NYR Nyrada Preclinical Program & Corporate Update Presentation
30/04/20		1.57MB	Share
NYR Change of Director's Interest Notice - JM
27/04/20		208.98KB	Share
NYR Appointment of New Chief Financial Officer
22/04/20		183.27KB	Share
NYR Preclinical Program & Corporate Update Global Webinar
20/04/20		184.56KB	Share
NYR Appendix 4C - March 2020 quarterly
14/04/20	PRICE SENSITIVE	1.17MB	Share
NYR Nyrada Newsletter Released
06/04/20		573.4KB	Share
NYR Update on Progress in Nyrada Programs
16/03/20		207.21KB	Share
NYR Nyrada Inc. Corporate Presentation February 2020
27/02/20		1.07MB	Share
NYR Appendix 4D and Half Year Accounts
25/02/20	PRICE SENSITIVE	943.38KB	Share
NYR Significant advance in Nyrada PCSK9i program published
11/02/20		6.22MB	Share
NYR Nyrada Inc - Chairman's letter to shareholders
20/01/20		241.39KB	Share
NYR Becoming a substantial holder
20/01/20		147.96KB	Share
NYR Nyrada Inc - Corporate Presentation
17/01/20		573.41KB	Share
NYR NOX: Listing of Nyrada Inc. spin-off on ASX
16/01/20		200.37KB	Share
NYR NYR Commences Trading on the ASX
16/01/20		345.32KB	Share
NYR Becoming a substantial holder
16/01/20		89.96KB	Share
NYR Becoming a substantial holder
16/01/20		82.94KB	Share
NYR Initial Director's Interest Notice
16/01/20		162.13KB	Share
NYR Initial Director's Interest Notice
16/01/20		165.68KB	Share
NYR Initial Director's Interest Notice
16/01/20		163.94KB	Share
NYR Initial Director's Interest Notice
16/01/20		162.98KB	Share
NYR Initial Director's Interest Notice
16/01/20		171.7KB	Share
NYR Initial Director's Interest Notice
16/01/20		165.45KB	Share
NYR Regulation S-Foreign Ownership Restrictions
15/01/20		767.37KB	Share
NYR Confirmation and Waiver under ASX Listing Rules
14/01/20		119.22KB	Share
NYR Pre-Quotation Disclosure
14/01/20		379.96KB	Share
NYR Updated Pro-forma - Financial Position and Commitments
14/01/20		128.46KB	Share
NYR Securities Trading Policy
14/01/20		153.48KB	Share
NYR Capital Structure and Restricted Securities
14/01/20		85.05KB	Share
NYR Financial Statements Year End 30 June 2019
14/01/20		937.93KB	Share
NYR Financial Statements Year End 30 June 2018
14/01/20		1.26MB	Share
NYR Corporate Governance Statement
14/01/20		331.77KB	Share
NYR Equity Incentive Plan
14/01/20		219.27KB	Share
NYR Amended and Restated Certificate of Incorporation and Bylaws
14/01/20		1.49MB	Share
NYR Supplementary Prospectus
14/01/20		92.64KB	Share
NYR Prospectus
14/01/20		4.48MB	Share
NYR Appendix 1A, Information Form and Checklist, Annexure 3
14/01/20		272.28KB	Share
NYR Distribution Schedule
14/01/20		63.39KB	Share
NYR Top 20 Securityholders
14/01/20		85.07KB	Share
NYR ASX Market Release - Admission and Quotation
14/01/20		252.98KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 28.5¢		Change -0.005(1.72%)		Mkt cap ! $68.05M

Open	High	Low	Value	Volume
28.5¢	28.5¢	28.0¢	$47.78K	167.7K

Buyers (Bids)

No.	Vol.	Price($)
2	164056	28.0¢

Sellers (Offers)

Price($)	Vol.	No.
29.0¢	147000	2

View Market Depth

No.	Vol.	Price($)
2	164056	0.280
2	46363	0.275
1	22700	0.265
1	20000	0.255
3	26848	0.250

Price($)	Vol.	No.
0.290	147000	2
0.300	61667	1
0.315	79365	1
0.320	451647	5
0.330	15000	1

Last trade - 15.28pm 09/09/2025 (20 minute delay)


Last 28.5¢		Change -0.005 ( 1.72 %)
Open	High	Low	Volume
27.5¢	29.0¢	27.5¢	108596
Last updated 15.28pm 09/09/2025 ?

NYR (ASX) Chart

NYRADA INC. - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories